U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H20O9
Molecular Weight 356.3246
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GENTIOPICRIN

SMILES

[H][C@@]3(O[C@@H]1OC=C2C(=O)OCC=C2[C@H]1C=C)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O

InChI

InChIKey=DUAGQYUORDTXOR-GPQRQXLASA-N
InChI=1S/C16H20O9/c1-2-7-8-3-4-22-14(21)9(8)6-23-15(7)25-16-13(20)12(19)11(18)10(5-17)24-16/h2-3,6-7,10-13,15-20H,1,4-5H2/t7-,10-,11-,12+,13-,15+,16+/m1/s1

HIDE SMILES / InChI

Molecular Formula C16H20O9
Molecular Weight 356.3246
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Gentiopicrin is a naturally occurring iridoid glycoside. It is a bioactive component of gentian species of medical plants. It has proved to be the strongest inhibitor of myeloperoxidase. It could be absorbed rapidly in mice, but with a low bioavailability, and could distribute to tissues extensively. Gentiopicrin has been reported to be effective against inflammatory conditions such as rheumatoid arthritis, liver illness, fever, digestive and intestinal disorders. Gentiopicrin treatment can exert anti-inflammatory effects on experimental acute colitis through attenuating the expression levels of TNF-α, IL-1β, IL-6, iNOS and COX-2, and it may present the therapeutic potential in the treatment of colitis. The drug inhibits reserpine-induced pain/depression dyad by downregulating GluN2B receptors in the amygdala. Gentiopicrin injection was approved by SFDA for the treatment of acute jaundice and chronic active hepatitis.

CNS Activity

Curator's Comment: Known to be CNS penetrant in mouse. Human data not available.

Originator

Sources: DOI: 10.1002/ardp.18621600105

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P05181
Gene ID: 1571.0
Gene Symbol: CYP2E1
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
[Determination gentiopicrin in biyanqingdu granulae by SPE-HPLC].
2005 Jun
[Inhibition of extracts from 17 Chinese herbs on periodontal pathogenic microbes].
2006 Aug
[Determination of ginsenoside rd in human plasma by LC/MS/MS].
2006 Sep
[Preparative separation of gentiopicrin from Radix Gentianae by high-speed counter-current chromatography with macroporous resin].
2007 Dec
Gentiopicrin-producing endophytic fungus isolated from Gentiana macrophylla.
2009 Aug
Antimicrobial activity of Gentiana lutea L. extracts.
2009 May-Jun
Anti-apoptotic activity of gentiopicroside in D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure.
2010 Oct 6
Patents

Sample Use Guides

Mice: 200, 100, and 50mg/kg once a day for 7days
Route of Administration: Oral
50, 500, and 1,500 ug/mL of gentiopicrin exhibited no significant toxicity to chondrocytes (P>0.05) after 24h.
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:41:06 UTC 2023
Edited
by admin
on Fri Dec 15 19:41:06 UTC 2023
Record UNII
0WE09Z21RC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GENTIOPICRIN
MI  
Common Name English
NSC-606402
Code English
GENTIOPICRIN [MI]
Common Name English
GENTIOPICROSIDE
Common Name English
(5R,6S)-5-ETHENYL-6-(.BETA.-D-GLUCOPYRANOSYLOXY)-5,6-DIHYDRO-1H,3H-PYRANO(3,4-C)PYRAN-1-ONE
Common Name English
Code System Code Type Description
MERCK INDEX
m5702
Created by admin on Fri Dec 15 19:41:06 UTC 2023 , Edited by admin on Fri Dec 15 19:41:06 UTC 2023
PRIMARY Merck Index
NSC
606402
Created by admin on Fri Dec 15 19:41:06 UTC 2023 , Edited by admin on Fri Dec 15 19:41:06 UTC 2023
PRIMARY
PUBCHEM
88708
Created by admin on Fri Dec 15 19:41:06 UTC 2023 , Edited by admin on Fri Dec 15 19:41:06 UTC 2023
PRIMARY
CAS
20831-76-9
Created by admin on Fri Dec 15 19:41:06 UTC 2023 , Edited by admin on Fri Dec 15 19:41:06 UTC 2023
PRIMARY
EPA CompTox
DTXSID40878043
Created by admin on Fri Dec 15 19:41:06 UTC 2023 , Edited by admin on Fri Dec 15 19:41:06 UTC 2023
PRIMARY
FDA UNII
0WE09Z21RC
Created by admin on Fri Dec 15 19:41:06 UTC 2023 , Edited by admin on Fri Dec 15 19:41:06 UTC 2023
PRIMARY
MESH
C012997
Created by admin on Fri Dec 15 19:41:06 UTC 2023 , Edited by admin on Fri Dec 15 19:41:06 UTC 2023
PRIMARY
ECHA (EC/EINECS)
244-070-2
Created by admin on Fri Dec 15 19:41:06 UTC 2023 , Edited by admin on Fri Dec 15 19:41:06 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT